<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang Y</submitter><funding>NIH HHS</funding><pagination>5552</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10705754</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(23)</volume><pubmed_abstract>Epithelial cell adhesion molecule (EpCAM) is a tumor-associated antigen that is frequently overexpressed in various carcinomas. We have developed chimeric antigen receptor (CAR) T cells specifically targeting EpCAM for the treatment of gastric cancer. This study sought to unravel the precise mechanisms by which tumors evade immune surveillance and develop resistance to CAR T cell therapy. Through a combination of whole-body CAR T cell imaging and single-cell multiomic analyses, we uncovered intricate interactions between tumors and tumor-infiltrating lymphocytes (TILs). In a gastric cancer model, tumor-infiltrating CD8 T cells exhibited both cytotoxic and exhausted phenotypes, while CD4 T cells were mainly regulatory T cells. A T cell receptor (TCR) clonal analysis provided evidence of CAR</pubmed_abstract><journal>Cancers</journal><pubmed_title>Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance.</pubmed_title><pmcid>PMC10705754</pmcid><funding_grant_id>R01-CA217059</funding_grant_id><funding_grant_id>R01-CA254035</funding_grant_id><pubmed_authors>Jin MM</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Louie R</pubmed_authors><pubmed_authors>Puc J</pubmed_authors><pubmed_authors>Alcaina Y</pubmed_authors><pubmed_authors>Vedvyas Y</pubmed_authors><pubmed_authors>Luciani F</pubmed_authors><pubmed_authors>Min IM</pubmed_authors><pubmed_authors>Britz M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance.</name><description>Epithelial cell adhesion molecule (EpCAM) is a tumor-associated antigen that is frequently overexpressed in various carcinomas. We have developed chimeric antigen receptor (CAR) T cells specifically targeting EpCAM for the treatment of gastric cancer. This study sought to unravel the precise mechanisms by which tumors evade immune surveillance and develop resistance to CAR T cell therapy. Through a combination of whole-body CAR T cell imaging and single-cell multiomic analyses, we uncovered intricate interactions between tumors and tumor-infiltrating lymphocytes (TILs). In a gastric cancer model, tumor-infiltrating CD8 T cells exhibited both cytotoxic and exhausted phenotypes, while CD4 T cells were mainly regulatory T cells. A T cell receptor (TCR) clonal analysis provided evidence of CAR</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-25T21:17:52.341Z</modification><creation>2025-04-06T08:40:59.187Z</creation></dates><accession>S-EPMC10705754</accession><cross_references><pubmed>38067255</pubmed><doi>10.3390/cancers15235552</doi></cross_references></HashMap>